MONICA LEID: Open Payments
NPI 1013280916 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,365 in 66 payments from 20 companies in 2025. Trend: 2023 $277 · 2024 $784 · 2025 $2,365
Food & beverage: $1,776Travel & lodging: $589
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 9 | $793 |
| Abbott Laboratories | 5 | $262 |
| ABBVIE INC. | 17 | $246 |
| AstraZeneca Pharmaceuticals LP | 2 | $224 |
| PFIZER INC. | 7 | $148 |
| Astellas Pharma US Inc | 2 | $147 |
| Collegium Pharmaceutical, Inc. | 7 | $131 |
| Stryker Corporation | 1 | $73 |
| Boston Scientific Corporation | 3 | $64 |
| Lilly USA, LLC | 2 | $43 |
Products named: INCEPTIV, PROCLAIM, Veozah, XTAMPZA, BREZTRI, FARXIGA, INTELLIS ADAPTIVESTIM, NURTEC ODT.
Industry payments across MD — which companies pay providers there.
